Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (31)

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  2. Incidence of refractory CMV infection with or without antiviral resistance in Spain: A systematic literature review

    Transplantation Reviews, Vol. 38, Núm. 1

  3. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

2023

  1. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  2. Dynamics of Human Anelloviruses in Plasma and Clinical Outcomes Following Kidney Transplantation

    Transplantation, Vol. 107, Núm. 2, pp. 511-520

2022

  1. Human genetic polymorphisms and risk of viral infection after solid organ transplantation.

    Transplantation Reviews, Vol. 36, Núm. 1

  2. Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates

    Transplant Infectious Disease, Vol. 24, Núm. 1

  3. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation

    Frontiers in Genetics, Vol. 13

  4. Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression

    Transplant Infectious Disease, Vol. 24, Núm. 2

2021

  1. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

  2. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19

    Transplantation, Vol. 105, Núm. 6, pp. 1372-1380

  3. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794

2020

  1. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

    The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487

  2. Early kinetics of Torque Teno virus DNA load and BK polyomavirus viremia after kidney transplantation

    Transplant Infectious Disease

  3. Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 1, pp. 166-171

2019

  1. Going beyond serology for stratifying the risk of CMV infection in transplant recipients

    Reviews in Medical Virology, Vol. 29, Núm. 1

  2. Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation

    American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1139-1149

  3. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

  2. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8